Toggle Main Menu Toggle Search

Open Access padlockePrints

Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA

Lookup NU author(s): Dr Marina DanilenkoORCiD, Sharanya Nath, Jack Baines, Freya Gordon, Swathi Merugu, Dr Lisa AllinsonORCiD, Aaron Potts, Angharad Goodman, Dr Samuel Kidman, Dr Ciaron McAnulty, Dr David JamiesonORCiD, Professor Deborah TweddleORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 by the authors.Neuroblastoma (NB) is an aggressive childhood cancer requiring intensive multimodal therapies in high-risk (HRNB) patients. Currently, invasive surgical biopsies are required to classify NB risk group and assign treatment based on the tumour genetic profile. Circulating tumour DNA (ctDNA) obtained from blood samples can be used to identify tumour biomarkers. Here we applied targeted next-generation sequencing (tNGS) using a panel of 42 genes to analyse 32 NB ctDNA samples for the presence of single-nucleotide variants and copy number changes from 28 patients in all NB risk groups. In two additional ctDNA samples, droplet digital PCR was used to detect hotspot ALK variants. Pathogenic mutations with a variant allele frequency (VAF) > 1% were identified in 13/32 (41%) ctDNA samples. ALK and PTPN11 were the most frequent, each being detected in 4/32 (13%) samples, together with oncogene amplifications. Targeted NGS of ctDNA detected actionable variants, including those absent in the diagnostic primary tumour due to spatial and temporal heterogeneity. Our findings confirm the usefulness of ctDNA in detecting genetic abnormalities in NB.


Publication metadata

Author(s): Danilenko M, Nath S, Baines J, Gordon F, Merugu S, Allinson LM, Potts A, Collins B, Goodman A, Kidman SE, McAnulty C, Jamieson D, Tweddle DA

Publication type: Article

Publication status: Published

Journal: International Journal of Molecular Sciences

Year: 2025

Volume: 26

Issue: 19

Online publication date: 27/09/2025

Acceptance date: 18/09/2025

Date deposited: 28/10/2025

ISSN (print): 1661-6596

ISSN (electronic): 1422-0067

Publisher: MDPI

URL: https://doi.org/10.3390/ijms26199466

DOI: 10.3390/ijms26199466

Data Access Statement: Data is contained within the article. Sequencing data has been deposited in NCBI SRA (BioProject accession number PRJNA928778).

PubMed id: 41096734


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Action Medical Research/Great Ormond Street Hospital Charity (GN2390)
Blood Cancer UK (CRCPSC-Dec21\100002)
Cancer Research UK (C8594/A23804)
Children’s Cancer North
Horizon Europe-Mission Cancer THRIVE grant (grant reference: 101136622)
Little Princess Trust (CCLGA 2016 08)
Newcastle Cancer Centre CTRQQR-2021\100003
Sir Bobby Robson Foundation

Share